Market Overview

Intra-Cellular Therapies Inc. (NYSE: ITCI)

15.82 +0.29 (1.87%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/03/20BTIG ResearchMaintainsBuy68.0
2/20/20Evercore ISI GroupInitiates Coverage OnOutperform
2/18/20Cantor FitzgeraldReiteratesOverweight47.0
1/31/20JP MorganDowngradesNeutral26.0
12/24/19Canaccord GenuityReiteratesBuy65.0
8/12/19JefferiesInitiates Coverage OnBuy16.0
8/08/19JMP SecuritiesReiteratesMarket Outperform21.0
11/15/18Leerink SwannInitiates Coverage OnOutperform27.0
11/13/18Leerink SwannInitiates Coverage OnOutperform27.0
8/23/18Cantor FitzgeraldInitiates Coverage OnOverweight32.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter